Drugmakers in Davos shift focus to chronic diseases of poor

DAVOS, Switzerland (Reuters) - Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest $50 million over three years to fight cancer and other non-communicable diseases in poor countries.